- ----------------------------
FORM 4
__ Check this box if no
longer subject to
Section 16. Form 4
or Form 5 obligations
may continue. See
Instruction 1(b).
(Print or type Responses)
- ----------------------------
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934.
Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f)
of the Investment Company Act of 1940.
- -------------------------------------
OMB Approval
- -------------------------------------
OMB Number: 3235-0287
Expires: September 30, 1998
Estimated average burden
hours per response...0.5
- -------------------------------------
<TABLE>
<CAPTION>
- --------------------------------------------------- ------------------------------------------------------ -------------------------
1. Name and Address of 2. Issuer Name and Ticker or Trading Symbol 6. Relationship of Reporting Person(s) to Issuer
Reporting Person* (Check all applicable)
__ Director __ 10% Owner
X Officer (give title below) __ Other (specify below)
Chief Operating Officer & Director of Drug Development
SHERRIS, David OXiGENE, Inc. (OXGN)
- ------------------------------------------------------------------------------------------------------------------------------------
(Last) (First) (Middle) 3. IRS or Social 4. Statement for 7. Individual or Joint/Group Reporting
Security Number of Month/Year (check applicable line)
Reporting Person X Form Filed by One Reporting Person
(Voluntary) 10/98 __ Form Filed by More than One Reporting
Person
c/o OXiGENE, Inc.
One Copley Place, Suite 602
- ------------------------------------------- ------------------
(Street) 5. If Amendment,
Date of Original
(Month/Year)
Boston, MA 02116
- ------------------------------------------------------------------------------------------------------------------------------------
(City) (State) (Zip) Table 1 -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
<S> <C> <C> <C> <C> <C> <C>
- ------------------------------------------ ------------- ----------------- ---------------------------------------------------------
1. Title of Security 2. Trans- 3. Transaction 4. Securities Acquired (A) 5. Amount of 6. Ownership 7. Nature of
(Instr. 3) action Code (Instr. or Disposed of (D) Securities Form: Indirect
Date 8) (Instr. 3, 4 and 5) Beneficially Direct (D) Beneficial
(Month/ Owned at End or Indirect Ownership
Day/ of Month (I) (Instr. 4)
Year) (Instr. 3 (Instr. 4)
and 4
- ------------------------------------------------------------------------------------------------------------------------------------
Code V Amount (A) or (D) Price
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 10/08/98 P 1,000 A $5.00 1,000 D
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, See Instruction 4(b)(v).
</TABLE>
<PAGE>
<TABLE>
FORM 4 (continued) Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
- ------------------------------------------------------------------------------------------------------------------------------------
1. Title 2. Conver- 3. Trans- 4. Trans- 5. Number of 6. Date 7. Title 8. Price 9. Number 10. Owner- 11. Nature of
of sion or action action Derivative Exer- and of of ship Indirect
Deri- Exercise Date Code Securities cisable Amount Deri- Deri- Form Beneficial
vative Price of (Instr. Acquired (A) and Expi- of vative vative of Deri- Ownership
Secu- Deri- (Month/ 8) or Disposed ration Under- Secu- Secu- vative (Instr. 4)
rity vative Day/ of (D) Date Lying rity rities Security:
(Instr. Security Year) (Instr. 3, (Month/ Securi- (Instr. Benefi- Direct
3) 4, and 5) Day/ ties 5) cially (D) or
Year) (Instr. Owned Indirect
3 and 4) at End (I)
of (Instr.
Month 4)
(Instr.
4)
--------------------------------------------------
Code V (A) (D) Date Expir- Title Amount
Exerci- ation or
sable Date Number
of
Shares
---------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses:
** Intentional misstatements or omissions of /s/ David Sherris November 2, 1998
facts constitute Federal Criminal -------------------------------------------- ------------------------------
Violations. David Sherris, Ph.D Date
See 18 U.S.C. and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one
of which must be manually signed.
If space provided is insufficient,
see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless form
displays a currently valid OMB number.
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, See Instruction 4(b)(v).
</TABLE>
